Sonendo logo

SonendoNYSE: SONX

Profile

Sector:

Healthcare

Country:

United States

IPO:

29 October 2021

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$155.14 M
-99%vs. 3y high
50%vs. sector
-vs. 3y high
-vs. sector
-97%vs. 3y high
94%vs. sector
-99%vs. 3y high
58%vs. sector

Price

regular market | Mon, 18 Nov 2024 14:30:00 GMT
$2.13+$0.02(+0.95%)

Dividend

No data over the past 3 years
$8.04 M$8.65 M
$8.04 M-$7.54 M

Analysts recommendations

Institutional Ownership

SONX Latest News

Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
businesswire.com11 November 2024 Sentiment: NEUTRAL

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will postpone the third quarter 2024 conference call that was previously scheduled for after the market close on Tuesday, November 12th, 2024. The Company still intends to file its audited financial results on November 12th, 2024, but has postponed, until further notice, the accompanying conference call. Mana.

Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
zacks.com05 November 2024 Sentiment: NEGATIVE

Sonendo (SONX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
seekingalpha.com10 August 2024 Sentiment: NEUTRAL

Sonendo, Inc. (OTCQX:SONX) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Corporate Participants Louisa Smith - IR, Gilmartin Group Bjarne Bergheim - President and Chief Executive Officer John Bostjancic - Chief Financial Officer Conference Call Participants Joe Federico - Stifel Financial Corporation Operator Good afternoon, and welcome to the Sonendo Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.

Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
zacks.com07 August 2024 Sentiment: POSITIVE

Sonendo, Inc. (SONX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.19 per share a year ago.

Sonendo, Inc. (SONX) Q3 2023 Earnings Call Transcript
Seeking Alpha11 November 2023 Sentiment: POSITIVE

Sonendo, Inc. (NYSE:SONX ) Q3 2023 Results Conference Call November 8, 2023 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group Bjarne Bergheim - President & Chief Executive Officer Michael Watts - Chief Financial Officer Conference Call Participants Tom Stephan - Stifel Jason Bednar - Piper Sandler Justin Wang - Morgan Stanley Operator Hello, and welcome to Sonendo's Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.

Why Is Sonendo (SONX) Stock Up 38% Today?
InvestorPlace04 October 2023 Sentiment: POSITIVE

Sonendo (NYSE: SONX ) stock is on the rise Wednesday despite the medical technology company recently receiving a delisting notice. That notice comes from the New York Stock Exchange and has to do with the price of SONX stock.

Sonendo, Inc. (SONX) Reports Q2 Loss, Misses Revenue Estimates
Zacks Investment Research09 August 2023 Sentiment: NEGATIVE

Sonendo, Inc. (SONX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.57 per share a year ago.

Sonendo, Inc. (SONX) Q1 2023 Earnings Call Transcript
Seeking Alpha13 May 2023 Sentiment: POSITIVE

Sonendo, Inc. (NYSE:SONX ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Louisa Smith - Gilmartin Group Bjarne Bergheim - President and CEO Michael Watts - CFO Conference Call Participants Tom Stephan - Stifel Nathan Rich - Goldman Sachs Erin Wright - Morgan Stanley Dan Clark - Bank of America Operator Good afternoon, and welcome to Sonendo's First Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

What type of business is Sonendo?

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

What sector is Sonendo in?

Sonendo is in the Healthcare sector

What industry is Sonendo in?

Sonendo is in the Medical Devices industry

What country is Sonendo from?

Sonendo is headquartered in United States

When did Sonendo go public?

Sonendo initial public offering (IPO) was on 29 October 2021

What is Sonendo website?

https://sonendo.com

Is Sonendo in the S&P 500?

No, Sonendo is not included in the S&P 500 index

Is Sonendo in the NASDAQ 100?

No, Sonendo is not included in the NASDAQ 100 index

Is Sonendo in the Dow Jones?

No, Sonendo is not included in the Dow Jones index

When was Sonendo the previous earnings report?

No data

When does Sonendo earnings report?

Next earnings report date is not announced yet